{"log_id": 6471129098675417617, "direction": 0, "words_result_num": 53, "words_result": [{"probability": {"variance": 4.1e-05, "average": 0.996219, "min": 0.969132}, "location": {"width": 845, "top": 164, "height": 25, "left": 163}, "words": "低于1000/mm3时,1μg/kg每日1次皮下或静脉注射给药。中性粒细胞数回升至5000/mm3以上时"}, {"probability": {"variance": 0.001263, "average": 0.983019, "min": 0.885574}, "location": {"width": 168, "top": 191, "height": 23, "left": 172}, "words": "的情减量或停止给药"}, {"probability": {"variance": 0.00763, "average": 0.977754, "min": 0.607295}, "location": {"width": 348, "top": 217, "height": 24, "left": 161}, "words": "6.用于促进骨髓移植患者中性粒细胞增加"}, {"probability": {"variance": 0.000446, "average": 0.993026, "min": 0.888627}, "location": {"width": 857, "top": 241, "height": 27, "left": 163}, "words": "成人在骨髓移植的第2日至第5日开始用药,2~5μg/kg每日1次皮下或静脉注射给药。儿童在骨髓"}, {"probability": {"variance": 0.000143, "average": 0.995904, "min": 0.938729}, "location": {"width": 903, "top": 269, "height": 25, "left": 164}, "words": "移植的第2日至第5日开始用药,2μg/kg每日1次皮下或静脉注射给药。中性粒细胞回升至"}, {"probability": {"variance": 0.002598, "average": 0.976502, "min": 0.754718}, "location": {"width": 452, "top": 295, "height": 25, "left": 162}, "words": "5000/mm3白细胞计数1000/m3)以上时,停止给药"}, {"probability": {"variance": 0, "average": 0.999771, "min": 0.999485}, "location": {"width": 106, "top": 322, "height": 22, "left": 168}, "words": "【不良反应】"}, {"probability": {"variance": 3e-06, "average": 0.999282, "min": 0.993213}, "location": {"width": 537, "top": 347, "height": 25, "left": 167}, "words": "1肌肉骨骼系统:有时会有肌肉酸痛、骨痛、腰痛、胸痛的现象"}, {"probability": {"variance": 1.4e-05, "average": 0.998745, "min": 0.979233}, "location": {"width": 678, "top": 373, "height": 25, "left": 161}, "words": "2消化系统:有时会出现食欲不振的现象,或肝脏谷丙转氨酶、谷草转氨酶升高"}, {"probability": {"variance": 0.000553, "average": 0.994134, "min": 0.866098}, "location": {"width": 530, "top": 401, "height": 23, "left": 162}, "words": "3.其他:有人会出现发热、头疼、乏力及皮疹,ALP、LDH升高"}, {"probability": {"variance": 1.1e-05, "average": 0.998078, "min": 0.984502}, "location": {"width": 623, "top": 425, "height": 24, "left": 178}, "words": "极少数人会出现休克、间质性肺炎、成人呼吸窘迫综合征、幼稚细胞增加"}, {"probability": {"variance": 1e-06, "average": 0.999307, "min": 0.997387}, "location": {"width": 70, "top": 451, "height": 23, "left": 168}, "words": "【禁忌】"}, {"probability": {"variance": 1.3e-05, "average": 0.998035, "min": 0.98064}, "location": {"width": 598, "top": 476, "height": 26, "left": 163}, "words": "1对粒细胞刺激因子过敏者以及对大肠杆菌表达的其他制剂过敏者禁用"}, {"probability": {"variance": 2e-06, "average": 0.999155, "min": 0.994764}, "location": {"width": 309, "top": 503, "height": 22, "left": 179}, "words": "严重肝、肾、心、肺功能障碍者禁用"}, {"probability": {"variance": 1e-06, "average": 0.999297, "min": 0.994773}, "location": {"width": 858, "top": 528, "height": 24, "left": 162}, "words": "3骨髓中幼稚粒细胞未显著减少的骨髓性白血病患者或外周血中检出幼稚粒细胞的骨髓性白血病患者"}, {"probability": {"variance": 2e-06, "average": 0.99895, "min": 0.996214}, "location": {"width": 106, "top": 554, "height": 23, "left": 168}, "words": "【注意事项】"}, {"probability": {"variance": 4e-06, "average": 0.998882, "min": 0.989735}, "location": {"width": 437, "top": 578, "height": 23, "left": 178}, "words": "本品应在化疗药物给药结束后24~48小时开始使用"}, {"probability": {"variance": 0.004373, "average": 0.987112, "min": 0.596025}, "location": {"width": 678, "top": 604, "height": 24, "left": 161}, "words": "2.使用本品过程中应定期每周监测血象2次,特别是中性粒细胞数目变化的情况"}, {"probability": {"variance": 1e-06, "average": 0.999337, "min": 0.995955}, "location": {"width": 620, "top": 629, "height": 24, "left": 161}, "words": "3对髓性细胞系统的恶性增殖(急性粒细胞性白血病等)本品应慎重使用"}, {"probability": {"variance": 6e-06, "average": 0.998935, "min": 0.987554}, "location": {"width": 525, "top": 656, "height": 22, "left": 179}, "words": "长期使用本品的安全有效性尚未建立,曾有报导可见脾脏增大"}, {"probability": {"variance": 0.000236, "average": 0.995808, "min": 0.898237}, "location": {"width": 856, "top": 681, "height": 25, "left": 163}, "words": "虽然本品临床试验未发生过敏反应病例,但国外同类制剂曾发生少数过敏反应(发生率<1/4000),可"}, {"probability": {"variance": 2e-06, "average": 0.99928, "min": 0.994522}, "location": {"width": 855, "top": 705, "height": 25, "left": 164}, "words": "表现为皮疹、荨麻疹、颜面浮肿、呼吸困难、心动过速及低血压,多在使用本品30分钟内发生,应立"}, {"probability": {"variance": 6e-06, "average": 0.998515, "min": 0.989411}, "location": {"width": 858, "top": 730, "height": 27, "left": 161}, "words": "即停用,经抗组织胺、皮质激素、支气管解痉剂和(或)肾上腺素等处理后症状能迅速消失。这些病"}, {"probability": {"variance": 2e-06, "average": 0.999198, "min": 0.994543}, "location": {"width": 216, "top": 759, "height": 23, "left": 161}, "words": "例不应再次使用致敏药物"}, {"probability": {"variance": 1e-06, "average": 0.999134, "min": 0.997586}, "location": {"width": 230, "top": 783, "height": 23, "left": 180}, "words": "本品仅供在医师指导下使用"}, {"probability": {"variance": 1e-06, "average": 0.998986, "min": 0.996357}, "location": {"width": 221, "top": 810, "height": 22, "left": 168}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 1e-06, "average": 0.999233, "min": 0.996308}, "location": {"width": 717, "top": 835, "height": 24, "left": 163}, "words": "孕期安全性尚未建立。当证明孕妇用药潜在利益大于对胎儿的潜在危险,应予以使用"}, {"probability": {"variance": 1e-06, "average": 0.999067, "min": 0.995409}, "location": {"width": 251, "top": 859, "height": 26, "left": 164}, "words": "哺乳期妇女用药前应停止哺乳"}, {"probability": {"variance": 7e-06, "average": 0.997456, "min": 0.992328}, "location": {"width": 102, "top": 887, "height": 21, "left": 172}, "words": "【儿童用药】"}, {"probability": {"variance": 0.000172, "average": 0.996275, "min": 0.913391}, "location": {"width": 855, "top": 911, "height": 26, "left": 163}, "words": "儿童患者慎用,并给予适当监测。由于该药对新生儿和婴幼儿的安全性尚未确定,建议不用该药。每"}, {"probability": {"variance": 3e-06, "average": 0.998949, "min": 0.991709}, "location": {"width": 744, "top": 938, "height": 24, "left": 162}, "words": "日用药的4月~17岁患者未发现长期毒性效应,其生长、发育、性征和内分泌均未改变"}, {"probability": {"variance": 3e-06, "average": 0.997526, "min": 0.995665}, "location": {"width": 105, "top": 965, "height": 22, "left": 168}, "words": "【老年用药】"}, {"probability": {"variance": 5e-05, "average": 0.997317, "min": 0.952806}, "location": {"width": 850, "top": 989, "height": 25, "left": 165}, "words": "老年患者的生理机能比较低下,需观察患者的状态,注意用量及间隔,慎重给药。其安全性和有效性"}, {"probability": {"variance": 0, "average": 0.99978, "min": 0.99956}, "location": {"width": 77, "top": 1017, "height": 19, "left": 164}, "words": "尚未建立"}, {"probability": {"variance": 1.4e-05, "average": 0.997009, "min": 0.989899}, "location": {"width": 148, "top": 1039, "height": 25, "left": 167}, "words": "【药物相互作用】"}, {"probability": {"variance": 2e-06, "average": 0.9988, "min": 0.993401}, "location": {"width": 507, "top": 1066, "height": 25, "left": 162}, "words": "尚不完全清楚。对促进白细胞释放之药物(如锂剂)应慎用"}, {"probability": {"variance": 0, "average": 0.999373, "min": 0.998957}, "location": {"width": 102, "top": 1093, "height": 22, "left": 168}, "words": "【药物过量】"}, {"probability": {"variance": 1e-06, "average": 0.999329, "min": 0.995745}, "location": {"width": 854, "top": 1116, "height": 24, "left": 164}, "words": "当使用本品超过安全剂量时,会出现尿隐血,尿蛋白阳性,血清碱性磷酸酶活性明显提高,但在五周"}, {"probability": {"variance": 2e-05, "average": 0.998333, "min": 0.979751}, "location": {"width": 838, "top": 1143, "height": 24, "left": 160}, "words": "恢复期后各项指标均可恢复正常。当注射本品剂量严重超过安全剂量时,会出现食欲减退,体重偏低"}, {"probability": {"variance": 0.000126, "average": 0.99712, "min": 0.926}, "location": {"width": 858, "top": 1168, "height": 25, "left": 161}, "words": "活动减弱等现象;出现尿隐血,尿蛋白阳性;肝脏出现明显病变。这些变化可以在恢复期后消除或减"}, {"probability": {"variance": 0, "average": 0.999726, "min": 0.999726}, "location": {"width": 23, "top": 1197, "height": 21, "left": 161}, "words": "轻"}, {"probability": {"variance": 1e-06, "average": 0.998939, "min": 0.997725}, "location": {"width": 107, "top": 1220, "height": 24, "left": 167}, "words": "【药理毒理】"}, {"probability": {"variance": 0.001048, "average": 0.989269, "min": 0.787352}, "location": {"width": 855, "top": 1245, "height": 26, "left": 163}, "words": "1药理:本品为利用基因重组技术生产的人粒细胞刺激因子(rhG-CSF)。与天然产品相比,生物活性"}, {"probability": {"variance": 0.001412, "average": 0.989264, "min": 0.748802}, "location": {"width": 857, "top": 1270, "height": 26, "left": 161}, "words": "在体内、外基本一致。rhG-CSF是调节骨髓中粒系造血的主要细胞因子之一,选择性作用于粒系造血祖"}, {"probability": {"variance": 2e-06, "average": 0.99884, "min": 0.99467}, "location": {"width": 525, "top": 1298, "height": 24, "left": 161}, "words": "细胞,促进其增殖、分化,并可增加粒系终末分化细胞的功能"}, {"probability": {"variance": 1e-06, "average": 0.998046, "min": 0.996488}, "location": {"width": 59, "top": 1324, "height": 23, "left": 162}, "words": "2毒理"}, {"probability": {"variance": 1.9e-05, "average": 0.998237, "min": 0.977283}, "location": {"width": 854, "top": 1347, "height": 26, "left": 165}, "words": "21急性毒性:小鼠尾静脉一次注射5040μg/kg本品,相当于一般临床注射用剂量的1000倍。连续观"}, {"probability": {"variance": 1e-06, "average": 0.999082, "min": 0.997445}, "location": {"width": 244, "top": 1376, "height": 24, "left": 161}, "words": "察10天,未观察到中毒反应"}, {"probability": {"variance": 0.000192, "average": 0.996314, "min": 0.905065}, "location": {"width": 849, "top": 1400, "height": 25, "left": 166}, "words": "2亚急性毒性:对小鼠给药4周(静脉、皮下注射),13周(静脉注射)的无作用剂量为1μg/kg/"}, {"probability": {"variance": 9e-05, "average": 0.996525, "min": 0.937041}, "location": {"width": 857, "top": 1426, "height": 25, "left": 161}, "words": "日。给予10μg/kg/日以上时,可见鼠后肢股骨内膜的骨吸收与骨形成、ALP上升、脾脏重量增加等现"}, {"probability": {"variance": 7e-06, "average": 0.998442, "min": 0.988462}, "location": {"width": 852, "top": 1451, "height": 25, "left": 164}, "words": "象。在4周、13周给药(静脉注射)试验中,这些现象在停药后消失。对猴给药4周、13周(静脉"}, {"probability": {"variance": 0.000168, "average": 0.994303, "min": 0.929021}, "location": {"width": 855, "top": 1475, "height": 27, "left": 160}, "words": "注射)的无作用剂量分别为10μg/kg/日、1μg/kg/日以上,用1000g/kg/日的剂量给药4周后发生"}, {"probability": {"variance": 0.001089, "average": 0.992944, "min": 0.76453}, "location": {"width": 856, "top": 1504, "height": 24, "left": 159}, "words": "急剧的白细胞数增加(为给药前的15~28倍),被认为是发生脑出血死亡的原因,而用100μg/kg/日"}], "language": 3}